{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-027044","form_type":"8-K","ticker":null,"cik":"0001169987","company_name":"HTG MOLECULAR DIAGNOSTICS, INC","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.130936+00:00","generated_at":"2026-06-14T04:44:03.018750+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"HTG Molecular Diagnostics receives Nasdaq delisting notice due to Chapter 11 filing; trading suspended June 15","bullets":["Delisting notice received June 6, 2023 from Nasdaq staff after company's Chapter 11 bankruptcy filing.","Trading of HTGM common stock suspended at open on June 15, 2023; Form 25-NSE to follow.","Nasdaq cited concerns over continued listing compliance, residual equity interest, and public interest.","Company does not intend to appeal the delisting determination."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-027044","json":"https://secwatch.observer/filing/0000950170-23-027044.json","markdown":"https://secwatch.observer/filing/0000950170-23-027044.md","text":"https://secwatch.observer/filing/0000950170-23-027044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1169987/000095017023027044/0000950170-23-027044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1169987/000095017023027044/htgm-20230606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:44:03.018750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6504f58de5b71e517f49eb12ca5663eb789e7bfc","claim":"HTG MOLECULAR DIAGNOSTICS, INC received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).","evidence_excerpt":"June 6, 2023, the Company received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of the Company's filing for protection under Chapter 11 of the U.S. Bankruptcy Code (the \"Filing\") and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock (the “Securities”) will be delisted from Nasdaq. Trading of the Securities will be suspended at the opening of business on June 15, 2023 and a Form 25-NSE will be filed with the Securities and","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1169987/000095017023027044/0000950170-23-027044-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Rules","value":"5101, 5110(b), IM-5101-1"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}